logo

For the Inventor, By the Inventor

Palo Alto, CA, United States of America

Gregory R Reyes

This inventor holds 27 USPTO granted patents, plus 1 CIPO patent, primarily in Viral Hepatitis Research. Top assignees: Genelabs Technologies, Inc., Genelabs, Incorporated, The United States of America as Represented by the Department of Health. Active years: 1991-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gregory R Reyes. Retrieved from https://idiyas.com/inventor/gregory-r-reyes

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27

% Patents Active = 96.3


Average Co-Inventor Count = 2.9

ph-index = 7

Forward Citations = 304(Granted Patents)


Company Filing History:

goldMedal18 out of 72 
 
Genelabs Technologies, Inc.
 patents
silverMedal5 out of 17 
 
Genelabs, Incorporated
 patents
bronzeMedal3 out of 1,217 
 
The United States of America as Represented by the Department of Health
 patents
4. 2 out of 16,025 
 
University of California
 patents
5. 1 out of 255 
 
The United States of America
 patents
6. 1 out of 3,696 
 
The United States of America, as Represented by the Secretary, Department of Health and Human Services
 patents
7. 2 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1991-2006

Loading Chart...
Loading Chart...
Areas of Expertise:
Hepatitis E Vaccine
DNA Amplification
HTLV Peptide Antigens
Hepatitis C Epitopes
Viral Agents
Molecular Cloning
Infection Detection
Retrovirus
27 patents (USPTO):Explore Patents
1. 7094406 - Enterically transmitted non-A/non-B hepatitis viral agent and characteristic epitopes thereof (2006-08-22),
2. 6455492 - Hepatitis E virus vaccine and method (2002-09-24),
3. 6379891 - Method of detecting HEV infection (2002-04-30),
4. 6229005 - DNA sequences of enterically transmitted non-A/non-B hepatitis viral agent (2001-05-08),
5. 6120988 - Method of detecting hev infection (2000-09-19),
6. 6107023 - DNA amplification and subtraction techniques (2000-08-22),
7. 5928861 - HTLV-I and HTLV-II peptide antigens and methods (1999-07-27),
8. 5885768 - Hepatitis E virus peptide antigen and antibodies (1999-03-23),
9. 5871933 - HTLV-I and HTLV-II peptide antigens and methods (1999-02-16),
10. 5859230 - Non-A/non-B/non-C/non-D/non-E hepatitis agents and molecular cloning (1999-01-12),
11. 5843639 - Hepatitis C virus epitopes (1998-12-01),
12. 5843636 - Hepatitis C virus epitopes (1998-12-01),
13. 5824649 - DNA sequences of enterically transmitted non-A/non-B hepatitis viral (1998-10-20),
14. 5814441 - HTLV-I and HTLV-II peptide antigens and methods (1998-09-29),
15. 5789559 - DNA sequences of enterically transmitted non-A/non-B hepatitis viral (1998-08-04),

Title: The Innovative Journey of Gregory R Reyes

Introduction: Gregory R Reyes, a visionary inventor based in Palo Alto, CA, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Gregory R Reyes holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a background in engineering and a passion for creating solutions to complex problems, Gregory R Reyes has had a successful career marked by numerous accolades and recognition for his pioneering work in various industries.

Collaborations: Throughout his career, Gregory R Reyes has collaborated with leading research institutions, universities, and tech companies to further develop and implement his innovative ideas, fostering a culture of creativity and progress.

Conclusion: Gregory R Reyes stands as a shining example of an inventor whose relentless pursuit of innovation has not only transformed industries but also inspired future generations to push the boundaries of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…